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Abstract
Aim: Schema therapy is becoming an increasingly popular psychological model for working 
with individuals who have a variety of mental health and personality difficulties. The aim of this 
review is to look at the current evidence base for schema therapy and highlight directions for 
further research.
Method: A systematic search of the literature was conducted up until January 2011. All studies 
that had clinically tested the efficacy of schema therapy as described by Jeffrey Young (Young, 
1994; Young et al., 2003) to individuals with psychopathology were considered. These studies 
underwent detailed quality assessments based on Scottish Intercollegiate Guidelines Network 
(SIGN-50) culminating in ten studies being included in the review.
Results:  Only one study was deemed high enough quality to base recommendations on. This 
lack of evidence demonstrates a gap between theory, practice and research. The culminative 
message (both from the popularity of this model and the small number of studies reviewed in 
this research) is of a theory which has the potential to demonstrate clinically effective 
outcomes. However, without high quality research in this field, as yet there is not enough 
evidence on which to make clinical recommendations.
Recommendations: It is imperative that psychological practice within the NHS be guided by 
high quality research that demonstrates efficacious, evidence based interventions. It is 
therefore recommended that researchers and clinicians working with schema therapy seek to 
demonstrate the clinical effectiveness of this model through ongoing research utilising high 
quality randomised controlled trials. 
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Introduction
Within the NHS, health professionals are continually striving to provide the best 
interventions and treatments available. With new psychological theories constantly 
evolving it is essential to ensure that clinical practice keeps pace with research evidence. 
In such dynamic environments, systematic reviews are starting to play an increasingly 
important role in assessing the existing evidence for psychological interventions (SIGN, 
2008). 
The aim of this review is to collate the current evidence base for one of the more recent 
psychological interventions; schema therapy (Young, 1994, Young et al., 2003). Over 
recent years this model has become increasingly popular with clinicians and academics 
who have started to test both the theoretical assumptions and clinical effectiveness of this 
model. However, due to the recency of both the model and research in this area, no other 
review has been conducted in this field to our knowledge.   
What is Schema Therapy?
Schema therapy was developed by Jeffery Young in the 1980’s with the goal of improving 
interventions for individuals who had personality disorders and more complex, chronic, and 
characterological difficulties. Such individuals are often considered ‘difficult to treat’ using 
traditional cognitive therapy, and are frequently described as ‘treatment failures’ (Young et 
al., 2003). From extensive clinical experience Young identified that such individuals 
appeared to benefit from some adaptations to traditional cognitive therapy. Overtime these 
adaptations evolved into schema therapy; a broad integrative model which overlaps with 
other models of psychopathology including cognitive behavioural therapy and 
psychodynamic models (Young et al., 2003).
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There are four main concepts that are central to schema therapy; these are Early 
Maladaptive Schemas, Coping Styles, Schema Domains and Schema Modes (Young et 
al., 2003). Early Maladaptive Schemas (EMS) are at the heart of model. Currently there 
are 18 EMS’s which are described as, ‘extremely stable and enduring themes, comprised 
of memories, emotions, cognitions, and bodily sensations regarding oneself and one’s 
relationship with others, that develop during childhood and are elaborated on throughout 
the individual’s lifetime, and that are dysfunctional to a significant degree’ (Young et al. 
2003, p.7). Young states that schemas are present in every human being, but that they are 
manifested in a more rigid and extreme way in cases of psychopathology. 
Early Maladaptive Schemas commonly develop in children who live within an environment 
which fails to meet their core emotional needs, or where they experience repeated 
episodes of abuse, neglect, hostility and criticism (Young et al., 2003). Depending on the 
child’s early environment the development of schemas can be grouped into 5 domains: 
disconnection and rejection, impaired autonomy and performance, impaired limits, other 
directness and over vigilance and inhibition. Each domain represents an important 
component of a child's core needs, for example, schemas in the disconnection and 
rejection domain typically originate in detached, cold, rejecting, withholding, lonely, 
explosive, unpredictable, or abusive families (Young et al., 2003). 
Coping styles refer to the ways a child adapts to these environments and experiences. 
There are three main coping strategies used; overcompensation (fighting the schema and 
acting as though the opposite were true), surrendering (or giving in to the schema) and 
avoidance (trying to avoid schema activation) (Young et al., 2003). Although these coping 
styles initially develop to help a child survive toxic environments, over time and in different 
environments, such strategies can serve to maintain the dysfunctional schemas and cease 
to serve the individual (Young et al., 2003).
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Schema modes are the most recent addition to schema therapy. Modes reflect the 
moment-to-moment emotional and behavioural state of a person at a given time. Modes 
comprise of clusters of schemas, for example, defectiveness and emotional deprivation 
are both part of the lonely child mode. Schema therapy and schema mode therapy do not 
reflect two separate entities, rather schema mode work is seen as an advanced 
component of schema therapy which is particularly beneficial when working with 
individuals who have borderline personality disorder or other complex needs. Such 
individuals often present with a number of schemas being simultaneously activated, which 
can make individual schema work more complex (Young et al., 2003). By allowing 
therapists to work with groups of schemas simultaneously, schema mode therapy can 
simplify therapeutic interventions for some individuals.
The Goal of Schema Therapy
Young et al., (2003) explain that a healthy person can adaptively meet their own core 
needs. The goal of schema therapy is to help those unable to do this. This may involve 
reducing forms of schema perpetuation which are behaviours that will reduce the likelihood 
of schema change, identifying maladaptive coping styles, healing unhelpful schemas and 
modes whilst developing healthier, more adaptive alternatives. This can be a long process 
which requires the individual to confront and modify or fight schemas that may have 
previously served a protective and adaptive function.
In schema therapy the therapeutic relationship is seen as the foundation for these 
changes to occur. As early maladaptive schemas and modes arise when core needs are 
not met, schema therapists aim to identify and meet these previously unmet needs within 
the therapy relationship. This may then progress to mobilising other supportive 
relationships. By helping the individual identify missed experiences or unmet needs in 
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early childhood and providing opportunities to address these within a therapeutic 
relationship, schema therapy serves as an antidote to the early damaging experiences that 
led to the formation of maladaptive schemas and modes. In schema therapy this is 
referred to as ‘limited reparenting’ (Young et al., 2003).
Why conduct this review?
Over the last 20 years, schema therapy has evolved into a model which is both simple to 
understand whilst also deep and complex in nature. The combination of these factors has 
resulted in it being a popular model with clinicians and researchers. The aim of this 
systematic review is to identify and consolidate the current clinical evidence base for 
schema therapy and suggest areas in need of future development. 
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Study Protocol
Review objective
To review the treatment evidence for schema therapy as described by Jeffrey Young 
(Young, 1994; Young et al., 2003).
Participants
Young suggests that schema therapy is not appropriate for all individuals. Indications that 
schema therapy may not be appropriate are...
1. Current major crises
2. Psychosis
3. Acute, untreated Axis I disorder
4. Current chronic substance misuse
5. When the presenting problem is situational and not related to a schema or life 
pattern.
6. When the individual is under the age of 18 as personality variables in younger 
people may still be forming. 
All study participants will be considered in relation to these recommendations. The only 
fixed exclusion criteria will be age. No study with participants under the age of 18 will be 
included in this review. 
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Psychopathology
Although schema therapy was originally developed to improve treatment outcomes for 
individuals with personality disorders and chronic characterological difficulties it is not 
resticted to this group. Schema therapy is recommended to be used with a variety of 
psychopathology. When individuals present with co-morbid Axis I and Axis II disorders, it is 
recommended that Axis I disorders are prioritised before addressing Axis II 
psychopathology. To ensure this review represents a broad range of individuals, all forms 
of intervention (for example, group and individual formats) and psychopathology will be 
considered. Due to the high prevalence of co-morbidity of mental health conditions it was 
considered clinically useful to include studies with participants who may have more than 
one mental health difficulty. It is anticipated that the there will be a greater prevalence of 
interventions targeted at treating personality disorders. 
Setting
The aim of this review is to evaluate schema therapy in a broad range of mental health 
settings to optimise its clinical utility, therefore both inpatient and out patient settings will be 
considered. 
Interventions
Due to the limited number of outcome studies in this area all studies that applied schema 
therapy to individuals with a mental health condition will be considered. Although it is 
anticipated that number of sessions will vary, only studies that evaluated the efficacy of a 
schema therapy intervention and exceeded ten sessions will be included in the review.
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Outcomes
As schema therapy may have a variety of different outcomes depending on the individuals 
unique needs all outcomes will be considered. 
Language 
Only English language studies will be included. 
Study Design
Ideally, systematic reviews only consider evidence from high quality randomised controlled 
trials. However, it is anticipated that there will be very few studies that will meet this 
criteria. Therefore, this review will include randomised controlled trials (RCT’s), controlled 
trials (CT) and uncontrolled trials (UT). Single case studies or studies with less than 5 
participants will be excluded from the review owing to the higher potential for bias in these 
study designs. Finally, economic evaluations and studies using duplicate data will not be 
included.
Method
The following search terms were used in this study; ‘schema therapy’ or ‘schema focused 
therapy’. However, for the purposes of this study, it will be referred to as ‘schema 
therapy’ (ST) which is now the most commonly used description.
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Search strategy
The following electronic databases were searched until the 10th January 2011.
• MEDLINE (from 1950); 
• EMBASE (from 1980); 
• CINAHL (from 1982); 
• the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane   Library 
2009, issue 3); 
• PsycINFO (from 1872);
Searching other resources
The reference lists of included and excluded studies were searched for additional studies 
and prominent researchers were contacted to enquire about other sources of information 
including ongoing research or unpublished data. Finally, two prominent schema therapy 
websites (the International Society for Schema Therapy, http://www.isst-online.com/ and 
Schema Therapy website, http://www.schematherapy.com) were also searched. 
Study selection
All titles and abstracts were initially screened and irrelevant studies or purely theoretical 
studies were excluded. The full text of all remaining studies were obtained and read. 
Studies utilising data previously reported were removed to prevent duplication. A flowchart 
of the selection process can be seen in Figure 1. 
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Figure 1. Flow chart of study selection process
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Titles and abstracts 
Screened n= 130
Full copies obtained 
and assessed for 
eligability n=103
Excluded n=27
(Not related to ST)
Publications to be 
revewed n=10
Studies identified 
through contact with 
experts n=1
Excluded n= 95
• Theoretical articles 
n=75
• Non-English language 
n= 8
• Not ‘Schema Therapy’ 
n= 3
• Unable to obtain n=1
• No outcome data n=2
• Dupilicate data n=1
• Less than 5 participants 
n=3
• Less than 10 sessions 
n=1
Included studies
Following this selection procedure ten studies met all the study requirements. These can 
be found in Table 1. In total three of the studies were considered to be assessing the 
effectiveness of ST in the treatment of BPD (Farrell et al., 2009; Giesen-Bloo et al., 2006; 
Nadort et al., 2009), two were targetting substance misuse and concurrent personality 
disorders (Ball, 2007; Ball et al., 2005), one looked at ST for PTSD (Cockram, Drummond 
& Lee (2010), one evaluated group schema therapy in an eating disorder population 
(Simpson et al., 2010), and three focused on individuals with agoraphobia and cluster C 
personality disorders (Gude & Hoffart, 2008; Gude, Monsen & Hoffart, 2001; Hoffart & 
Sexton, 2002). 
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Table 1. Summary of included studies.
Study Reference Aim Design Intervention Outcome 
Measures
Conclusions
Ball, S. A. (2007). 
Comparing individual 
therapies for personality 
disordered opioid 
dependent patients.
To compare Dual Focus Schema 
Therapy (DFST) to a 12 Step 
Facilitation Therapy (12FT) in 30 
partipants (15 male and 15 
female) with a diagnosed 
personality disorder and 
concurrent substance misuse
RCT Six months of 
either DFST 
or 12FT.
Substance use time 
line calender; 
Addiction Severity 
Index; Brief 
Symptom Index; 
Multiple Affect 
Adjective 
Checklist-Revised; 
Working Aliiance 
Index.
Both groups demonstrated a 
reduction in substance misuse, 
this was more rapid in the DFST 
condition. Participants reported a 
stronger therapeutic alliance in 
the DFST condition. Reduction 
in dysphoric affect did not occure 
in the DFST but did in the 12FT 
group
Ball et al., (2005).
Substance abuse and 
personality disorders in 
homeless drop-in center 
clients: Symptom 
severity and 
psychotherapy retention 
in a randomized clinical 
trial.
To compare Dual Focus Schema 
Therapy (DFST) to standard 
group substance abuse 
counselling (SAC) in 52 male 
homeless clients with a diagnosed 
personality disorder and 
concurrent substance misuse.
RCT 24 weeks of 
either  DFST 
or SAC. 
Due to low 
retention of 
participants so was 
only able to 
provide outcome 
data on utilisation 
of therapy.
Greater utilisation of DFST 
overall however, individuals with 
more severe personality disorders 
utilised SAC more than DFST. 
Cockram, Drummond 
& Lee (2010). 
Role and treatment of 
early maladaptive 
schemas in Vietnam 
veterans with PTSD. 
(Study Two)
To compare SchemaTherpy (ST) 
with traditional CBT (TCBT) for 
the treatment of PTSD in war 
veterans. TCBT was delivered to 
127 individuals between 1996 
and 2002. ST was delivered to 54 
veterans between 2007 and 2008.
CT 190hrs of 
either ST or 
TCBT.
PTSD Checklist 
Military;
Young Schema 
Questionnaire-L3; 
Hospital Anxiety 
and Deperession 
Scale
PTSD symptoms, anxiety, 
depression and EMS decreased 
significantly following ST. When 
compared to TCBT, the ST group 
showed significantly greater 
reductions in PTSD and anxiety 
symptoms.
Farrell, Shaw Webber, 
(2009).
A schema-focused 
approach to group 
psychotherapy for 
outpatients with 
borderline personality 
disorder: a randomised 
controlled trial.
This study tests the effectiveness 
of adding an eight month, thirty 
session schema focused therapy 
(ST) group to treatment as usual 
(TAU) for 32 women with a 
diagnosis of borderline 
personality disorder (BPD).
RCT Either eight 
months (30 
sessions) of 
group ST and 
TAU or just 
TAU.
Borderline 
Syndrome Index; 
SCL-90R, 
Diagnostic 
Interview for 
Borderline 
Personality 
Disorders -Revised; 
Global Assessment 
of Functioning 
Scale. These were 
administered pre-
treatment, post-
treatment, and 6-
month follow up.
At the end of the treatment 94% 
of ST + TAU group no longer 
met the criterion for BPD, whilst 
only 16% of TAU no longer met 
the criterion. Significantly lower 
scores on BSI, DIB-R and 
SCL-90R and higher scores on 
the GAF. These effects were 
maintained at six-month follow 
up.
Giesen-Bloo et al,  
(2006)
Outpatient 
Psychotherapy for 
Borderline Personality 
Disorder, 
To compare the effectiveness of 
schema therapy (ST) and 
transference focused therapy 
(TFT) in 88 patients with a 
diagnosed borderline personality 
disorder (BPD) index score above 
20.
RCT Two sessions 
per week for 
three years of 
either ST or 
TFT. 
Borderline 
Personality 
Disorder Severity 
Index score (4th 
version); Quality of 
life; general 
psychopathological 
dysfunction; and 
measures of 
schema therapy/
transference 
focused 
psychotherapy 
personality 
concepts. 
Three years of schema therapy or 
transference focused 
psychotherapy reduced BPD 
specific (and general) 
psychopathologic dysfunction; 
improved quality of life, 
increased model specific 
concepts.
The BPDSI-IV demonstrated ST 
to be more effective than TFT on 
the following sub scales; 
abandonment fears (p=.04), 
relationships (p=.03); identity 
disturbance (p=.02), impulsivity 
(p=.03, para-suicidal behaviour 
(p=.04) and dissociative and 
paranoid ideation (p=.02). No 
significant differences were 
found on the other sub scales.
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Study Reference Aim Design Intervention Outcome 
Measures
Conclusions
Gude & Hoffart, 
(2008).
Change in interpersonal 
problems after cognitive 
agoraphobia and 
schema-focused therapy 
versus psychodynamic 
treatment as usual of 
inpatients with 
agoraphobia and cluster 
C personality disorders.
Will ST increase interpersonal 
functioning more than TAU in 
patients with panic disorder, 
agoraphobia and co-occurring 
cluster C traits?
CT 12 weeks of 
either group 
TAU or group 
ST.
IIP, Symptom 
Check List -90; 
Mobility Index for 
Agoraphobia. 
These were 
administered at 
pre-treatment, 
discharge and  
follow-up.
Patients in the ST group showed 
greater improvement in 
interpersonal function than 
treatment as usual.
Gude, T., Monsen, J. 
T., & Hoffart, A. 
(2001) 
Schemas, affect 
consciousness, and 
Cluster C personality 
pathology: a 
prospective one-year 
follow-up study of 
patients in a schema-
focused short-term 
treatment program.
To determine if a low level of 
affect consciouness will be 
related to a high level of cluster C 
pathology at pretreatment; if 
change in cluster C pathology is 
influenced by change in affect 
consciousness; affect 
consciousness will any change 
during schema focused phase.
One 
group 
(pre-post 
design)
11 week 
inpatient 
group; 5 
weeks 
cognitive 
treatment of 
panic/
agoraphobia 
and 6 weeks 
ST.
The Affect 
consciousness 
Interview; Mobility 
Inventory and the 
Structured Clinical 
Interview for DSM 
IV.
Pretreatment level of affect 
consciousness did not correlate 
with Cluster C personality 
indexes but the Avoidant index 
did at post-treatment. Affect 
consciousness changed during 
the ST phase but not the CT 
phase. These results indicate that 
ST may increase affect 
consciousness more than CT.
Hoffart, Sexton, (2002) 
The role of optmism in 
the process of schema-
focused cognitive 
therapy of personality 
problems.
To examine the role of optimism 
in the process of ST in 35 patients 
with panic disorder and or 
agoraphobia and DSM-IV Cluster 
C personality traits.
One 
group 
(pre-post 
design)
11 week 
inpatient 
group; 5 
weeks 
cognitive 
treatment of 
panic/
agoraphobia 
and 6 weeks 
ST.
The Affect 
consciousness 
Interview; Mobility 
Inventory, the 
Structured Clinical 
Interview for DSM 
IV, Panic Rating 
Scale, the State-
Trait Anxiety 
Inventory, Schema 
Questionnaire and 
the Inventory of 
Interpersonal 
Problems.
Positive association between 
optimism and schema processes 
and between EMS and level of 
distress, empathy, insight and 
therapists optimism.
Nadort et al., (2009) 
Implementation of 
outpatient schema 
therapy for borderline 
personality disorder 
with versus without 
crisis support by the 
therapist outside office 
hours: A randomised 
controlled trial.
Question 1. To evaluate the 
success of implementing 
outpatient schema focused 
therapy for 62 individuals with a 
diagnosis of BPD and to 
determine the added value of 
therapist telephone availability 
outside office hours in case of 
crisis.
RCT two 45 min 
sessions per 
week for 18 
months either 
with or 
without 
therapist crisis 
support
Borderline 
Personality 
Disorder Severity 
Index score(fourth 
version); EuroQol, 
WHOQol, BPD-47, 
SCL-90 
No additional effect of extra 
crisis support with telephone 
availability were found.
Question 2. A second aim was to 
compare the outcomes of this 
study with the previous RCT 
conducted by Giesen-Bloo et al, 
2006 to determine if similar 
outcomes would be found in 
regular practice.
CT Nadort et al’s 
study: two 45 
min sessions 
per week for 
18 months 
Giesen-Bloo 
et al’s study: 
Two sessions 
per week for 
three years of 
either ST or 
TFT.
As above. ST can be successfully 
implemented in regular mental 
healthcare. Treatment results and 
drop out were comparable to a 
previous clinical trial. 
Simpson, Morrow, 
Van VreeswijK, Reid, 
(2010) 
Group schema therapy 
for eating disorders: A 
pilot study.
To evaluate the effectiveness of 
group schema therapy for 8 
individuals with a diagnosed 
eating disorder and co-morbid 
Axis I and II conditions. 
Pre-post 
test case 
series 
design
20 group 
schema 
therapy 
sessions
EDE-Q, YSI-L2, 
HADS, EQ5-D and 
the Experience of 
shame scale.
Results indicated that 4 of the 6 
had clinically sig improvement in 
eating. By follow up all 
completers had achieved over 
60% improvement in schema 
severity. 
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Quality Assessment
In order to differentiate between strong and weak evidence, quality assessments were 
carried out on all studies. To assist with these assessments the Scottish Intercollegiate 
Guidelines Network were used (SIGN 50). These checklists provided a framework to rate 
the methodological quality of each study. Based on these ratings each study was given 
one of the following overall quality ratings; 
• ‘A’ was awarded to high quality randomised controlled trails which met all or most of the 
quality criteria and when not fulfilled the conclusions in the study were deemed very 
unlikely to alter.
• ‘B’ was awarded to randomised controlled trials and controlled trials which met most of 
the quality criteria and when the conclusions in the study were deemed unlikely to alter.
• ‘C’ was awarded to randomised controlled trial or controlled trials when few or none of 
the quality criteria had been fulfilled and the conclusions of the study were deemed likely 
or very likely to alter. 
• ‘D’ was awarded to single group designs and uncontrolled studies or studies which met 
few of the quality criteria.
To try and minimise bias in ratings two studies (20%) were rated again by an independent 
rater and compared to the existing assessment. No differences were found between the 
researcher’s assessment and the independent researcher’s assessment on either study. 
Table 2 summarises the quality criteria ratings for this study. 
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(quality table to be inserted here)
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Discussion of results
Schema therapy for BPD
In total, three studies looked at the effectiveness of schema therapy (ST) in treating 
borderline personality disorder (BPD). Of these, one compared treatment as usual (TAU) 
to TAU with group ST (Farrell et al., 2009), another compared schema therapy to 
transference focused therapy (TFT) (Giesen-Bloo et al., 2006) and the other study 
compared ST with therapist telephone support to ST without therapist telephone support 
(Nadort et al., 2009). Overall the outcomes of these studies suggest ST may be effective in 
decreasing BPD symptoms. However, there are some methodological issues that should 
be considered when interpreting these results. Although all had a control condition, in 
order to determine the effectiveness of ST it is important to compare it to other therapies 
that have demonstrated effectiveness in treating BPD. For example, Transference-focused 
therapy has demonstrated some efficiacy in reducing BPD symptoms in a previously 
conducted randomised controlled trial (Clarkin et al., 2007) and it also shares some 
characteristics with ST. For example, both aim to change personality structure, reduce self 
destructive behaviours and increase quality of life (Giesen-Bloo et al., 2006). Additionally, 
both therapies can be offered in equal frequency and duration making TFT a good control 
condition. TFT was therefore a good choice as a control group for the Giesen-Bloo et al’s 
(2006) study.
The study by Nadort et al., (2009) was set up as an ‘implementation study’ to determine 
whether the results found in Giesen-Bloo et al’s (2006) randomised controlled trial could 
be replicated in general practice. For this reason they did not use a different treatment 
control, rather it directly compared results with the earlier study. After the intervention 
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phase results and drop out rates were comparable between the two studies. This suggests 
that ST could be successfully implemented in regular practice. Although this type of study 
is important as it attempts to demonstrate efficacy in real health settings (rather than the 
controlled conditions found in a RCT) there are some methodological weaknesses which 
could be adressed. Firstly, when comparing the participant characteristics before 
intervention between these two studies, the participants in the ‘implementation study’ 
displayed lower BPSI scores, less medication use and higher reported quality of life 
(Nadort et al., 2009). Therefore this group may have been somewhat less severe than 
those in the earlier clinical trial by Giesen-Bloo et al (2006). Nevertheless, all participants 
did meet full criteria for BPD in both studies. Secondly, participants received interventions 
in different settings and thirdly, the participants were recruited in different time frames. 
Although the setting is a key factor in being able to generalise the findings to general 
practice both these factors increase the differences between the ‘implementation study’ 
and the earlier RCT. Ideally, future research attempting to demonstrate efficacy in general 
practice should use a simultaneous active treatment control allowing randomisation to 
either ST or the control group. However, practically this design might be difficult to achieve 
outside in regular clinical practise. Under such circumstances a well conducted quasi 
experimental design controlling for baseline differences may be a more achiveable design
(Emmelkamp & Vedel, 2009).
However, despite these limitations, the study by Nadort et al, (2009) provides clinically 
useful information. One of the main aims of this research was to determine the added 
benefit of out of hours therapist telephone support to the treatment outcomes. Telephone 
support has been one of the more controversial aspects of schema therapy within an NHS 
setting and potentially may deter therapists from using this model. Interestingly, this study 
suggested that there was no added benefit of telephone support which may make this 
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therapy more accessible and less onerous for therapists working in settings not set up to 
support this aspect of schema therapy. 
The final study looking at ST for the treatment of BPD was conducted by Farrell et al., 
(2009). This study appears to show the largest benefits in reducing BPD symptoms 
suggesting that 94% of participants attending their ST group (in addition to treatment as 
usual (TAU)) no longer meeting the criteria for BPD. However, other factors could account 
for some of these benefits making it difficult to base clinical recommendations on this 
findings of this study alone. Firstly, the ST condition received greater frequency of 
therapeutic input having an additional 90 minutes structured clinical contact per week 
which was specifically targeted towards reducing BPD symptoms. It is possible that the 
structured group environment, targeted content and additional time may account for some 
of the perceived differences rather than the schema therapy component. As each 
treatment is likely to have its own structure it can be difficult to match one type of therapy 
with another. This is a more general difficulty when investigating psychological therapies. 
Ideally, In order to establish if ST is the primary change factor, future research should 
compare group ST a control treatment that is as equally structured, targeted and intense 
as possible. Additionally, the participant numbers in this study are very small making it 
difficult to generalise the findings. 
Overall, of the three studies reviewed the most compelling evidence for the effectiveness 
of schema therapy in treating BPD comes from Giesen-Bloo et al’s., (2006) study. The 
rigorous assessment procedures, regular quality checks, standardised outcome measures 
and evidence-based treatment control are particular strengths in this research. However,  
further large scale research is needed to replicate these findings before robust 
recommendations can be made for clinical practice. 
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Possible challenges to research in this area
Ideally, it is recommended that future research of similar quality to Giesen-Bloo et al’s 
(2006) study comparing ST to a suitable control treatment (such as TFT or Dilaectical 
Behaviour Therapy (DBT), Linehan et al., 2006) is needed in order to determine the 
evidence base for ST in general clinical practice. However, realistically it is acknowledged 
that there may be some difficulties doing this type of research within healthcare 
organisations with resource pressures, such as the UK National Health Service (NHS). 
Firstly, working with individuals with personality disorders (for example BPD) is often 
associated with co-existing mood disorders, substance misuse, eating disorders and post 
traumatic stress disorder (Binks et al., 2009). BPD in particular is also associated with 
other personality disorders, high rates of suicide when associated with mood disorders or 
alcoholism (Stone, 1990), and deliberate self-harm (Lineman, 1993). These issues make 
therapeutic work at times both demanding and challenging. Clinicians working in this field 
require high levels of skill as well as supervision and team support. 
Secondly, clinicians working within healthcare organisations need to have managerial 
support for both their clinical time and resources. ST is still relatively new and un-
researched. It is also longer in duration and therefore more expensive than other 
treatments. Within the current economic climate it may be challenging to get managerial 
support for ST research within healthcare departments that might be under pressure to 
provide time limited evidenced based treatments. It might be helpful for clinicians seeking 
funding for such research to read the economic evaluation by van Asselt et al., (2008). 
This evaluation looks at the overall costs of BPD and compares this with the treatment 
costs. Although it is beyond the scope of this evaluation to go into this paper in more 
depth, this evaluation appears to provides compelling evidence to suggest that ST, is a 
cost effective treatment when taking into account the wider costs associated with 
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supporting clients with personality disorders both within the NHS in addition to wider 
societal costs.
Thirdly, and finally, even when all the above difficulties have been overcome, ethics 
committees may still have concerns about approving implementation of such a new 
treatment. Overall, these difficulties may explain the scarcity of research into ST.
Research recommendations
Despite these challenges, reseach in this field is needed. Therefore clinicians who work in 
this field need to balance the needs of individuals with personality disorders with, succinct, 
cost effective treatments. The complex nature of personality disorders is likely to require 
them to provide more intensive interventions therefore it may be important to look at ways 
this can be achieved within the healthcare organisations such as the NHS. For example, 
rather than individual sessions, group ST may be a viable alternative. This is supported by 
Farrell et al’s (2009) study which suggests that group processes may improve the 
effectiveness of ST whilst also reducing the length of treatment required.
Finally, although difficult to perfectly match psychological therapies in terms of intensity, 
duration, structure and treatment goals, future research should aim to use control 
conditions which are as similar to ST as possible. Additionally, It is also important to 
compare ST to evidenced based alternatives. The most recent Cochrane Review on 
psychological treatments for BPD indicates Dialectical Behaviour Therapy (Linehan et al., 
2006) has the strongest evidence for treating BPD (Binks et al., 2009). Although it should 
also be recognised that this recommendation may be somewhat based on the quantity of 
evidence for DBT compared to other treatments (Vedel & Emmalkamp, 2010). For 
example, most treatments only have one or two published PCT demonstrating there 
effectiveness whilst DBT has seven (Vedel & Emmalkamp, 2010). This makes DBT the 
22
most robust evidence for BPD. In order to ensure individuals are being offered the most 
efficacious treatments available, it may be beneficial to compare ST with Dialectical 
Behaviour Therapy in a high quality randomised controlled trial. 
Schema Therapy for PTSD
The study by Cockram, Drummond & Lee (2010) aimed to determine if group ST would 
reduce PTSD symptoms in war veterans compared to a comparison CBT group that was 
previously run in the clinic. The main difference between the ST group and the CBT group 
was the content of six cognitive restructuring sessions. In the ST group, these six sessions 
focussed exclusively on schema work and included trauma imagery which allowed 
reprocesssing of childhood experiences. There was also reference to how early 
experiences could have made some individuals more vulnerable to PTSD which was 
absent in the CBT group. Overall, this study suggests the ST group had significantly better 
outcomes than the CBT group in reducing PTSD symptoms and anxiety. There was no 
significant difference between the ST and CBT group in depressive symptoms.
This study benefits from having a control condition which was similar in content, structure 
and duration to the ST group. However, there are some methodological and statistical 
weaknesses which could be addressed in future research. In this study, the participants 
were recruited during different time frames which meant that randomisation was not 
possible. Additionally,  it is possible that other changes in the clinic may have impacted on 
the outcomes; for example, treatment fidelity and therapist experience were not reported in 
this study.
A particular strength of this study was the measurement of schema change. As the primary 
aim of schema therapy is to reduce the impact of early maladaptive schemas, more 
studies would benefit from formal assessment of schema change. Unfortunately as data 
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was collected retrospectively the control CBT group had not completed a post intervention 
schema measure. As the content and structure of these groups had large amounts of 
overlap, it would be interesting to determine if the relatively small amount of schema 
change work in the ST group impacted upon early maladaptive schemas as compared to 
the control CBT group. This flaw makes it impossible to determine if schemas reduced 
more in the ST than in the CBT group. 
Overall, this study provides an indication that further research in this area would be 
benficial. Ideally large scale randomised controlled trials comparing individual and group 
interventions for PTSD are needed. Additionally, it would be interesting to look at 
interventions that target PTSD that had arisen from a greater variety of trauma 
experiences. It would also be beneficial to compare ST to other psychological interventions 
which have evidence in treating trauma such as Prolonged Exposure (Foa et al., 2007), 
Cognitive Restructuring (Ellis & Harper, 1975) or Eye Movement Desensitisation and 
Reprocessing (Shapiro, 2001).
Schema therapy for agoraphobia and cluster C personality disorders
Three studies have investigated the evidence for applying group ST to inpatients with 
agoraphobia and cluster C personality disorders (Gude & Hoffart, 2008; Gude, Monsen & 
Hoffart, 2001; Hoffart & Sexton, 2002). Two of these studies had no control conditions 
(Gude, Monsen & Hoffart, 2001; Hoffart & Sexton, 2002) making any inference about ST 
impossible as the benefits may be due to psychological contact or the inpatient 
environment. The other had a control condition that differed in type of group (one was 
open the other closed) content, structure and possible behavioural experiments (Gude & 
Hoffart, 2008). Any one of these differences may have influenced the difference in 
outcomes. An important note made by the authors was also the different data collection 
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procedures used. The comparison group were sent the follow-up questionnaires by post 
whilst the ST group had personal interviews. It is known that personal interviews can result 
in more favourable outcomes due to the potential of participants wanting to please the 
researcher. 
Overall, the lack of control groups in these studies makes it difficult to draw clear 
conclusions. However these initial promising findings suggest that future larger scale, high 
quality RCTs are warranted.
Dual focus schema therapy for substance misuse
Two studies were found that targeted substance misuse and concurrent personality 
disorders (Ball, 2007; Ball et al., 2005). The research in this area was difficult to review for 
a number of reasons. Firstly, the authors of this research described difficulties retaining 
participants and collecting data. Secondly, there was an absence of power calculations 
which potentially means the sample size may have been too small to detect effects. 
Thirdly, the main outcome measures were reductions in substance use, not reduction in 
early maladaptive schemas. 
Although schema therapy may benefit individuals who use substances, care should be 
taken to ensure participants are not contra-indicated for therapy. For example, participants 
should be screened to ensure they are not actively withdrawing, facing other crises and 
are stable in other respects (Young et al., 2003). When this is not possible, it must be 
recognised that such influences may impact on an the effectiveness of ST. Future research 
should also evaluate schema change as one of the outcome measures, as this is the 
primary goal of schema therapy. Ideally, control groups should be run with an evidenced 
based treatment alternative delivered in an equally structured, focused and intensive way 
using the same outcome measures to the ST condition. Practically, this may prove difficult 
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to substantiate within the NHS where therapies for this population are few and far 
between. Furthermore, future studies should evaluate schema and personality change as 
well as substance misuse. Finally, to achieve a high quality randomised controlled trial in 
this area care should be taken to address the difficulties that were encountered and 
described by these studies. This will likely involve putting procedures in place to overcome 
the difficulties found in relation to recruitment, retention and data collection. 
Schema therapy for eating disorders
To our knowledge only one pilot study has attempted to look at the effectiveness of 
schema therapy in an eating disorder population (Simpson et al., 2010). This study had a 
very small number of partipants (8) and no control group. For these reasons clinical 
recommendations cannot be based on this study alone. Despite this study’s small size it 
benefits from having sound outcome measures including schema severity administered at 
regular intervals and in controlled way. Reductions were found in eating disorder severity, 
anxiety and shame whilst quality of life increased.  These benefits resulted in large effect 
sizes at the six month follow up. The benefits of this pilot study demonstrate that further 
research is warranted in this area. Future research should use a control condition to 
ensure that the benefits were attributable to the schema therapy component rather than 
other factors (such as a well run, structured and closed group).
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Summary and recommendations
Overall this review highlights the gap between the clinical popularity of schema therapy 
and the evidence base. Within the current economic climate, without a strong evidence 
base it may become difficult for clinicians to justify the use of this therapy. In order to 
establish itself as an evidence based treatment, clinicians and researchers need to plan 
and implement studies of a similar methodological standard to the study by Giesen-Bloo et 
al (2006). Such research with the personality disorder population would likely involve a 
large funding application to ensure that the necessary resources are available. As 
previously discussed, within the current economic climate such funding may be difficult to 
secure. It is recommended that the economic evaluation by van Asselt et al., (2008) is 
referred to as a way to demonstrate ST can be a cost-effective treatment.
Overall, the area appears to benefit from using good screening and assessment measures 
but needs to focus on some key areas. These are:
1. Using randomised controlled designs with larger participant numbers.
2. Using power calculations when planning sample size.
3. Ensuring control groups comprise of evidence based treatment alternatives or that 
control for ‘non-specific effects’ such as therapist contact, support etc. 
4. Planning quality assessments and ensuring regular schema therapy training and 
supervision for the therapists.
5. Measuring schema change as an essential outcome measure.
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6. Ensuring the intervention is accessible to clinicians by exploring time frames and 
formats that can be implemented within clinical psychology services in healthcare 
organisations such as the National Health Service. As previously mentioned, this might 
included looking further at ST groups or using single case experiments in routine 
practice as an alternative way of gathering data.
Finally, no one has yet systematically reviewed the theoretical evidence for schema 
therapy. A theoretical review of ST would make an interesting and clinically useful 
contribution to the literature.
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